Network
Bart Westerman
- AII - Cancer immunology (VUmc) - Associate Professor
- CCA - Treatment and quality of life (VUmc) - Associate Professor
- Neurosurgery (VUmc) - Associate Professor
Person: Academic
Tom Würdinger
- AII - Cancer immunology (VUmc) - Full Professor
- CCA - Cancer biology and immunology (VUmc) - Full Professor
- CCA - Imaging and biomarkers (VUmc) - Full Professor
Person
David Noske
- CCA - Cancer biology and immunology (VUmc) - Medical Specialist
- AII - Cancer immunology (VUmc) - Medical Specialist
- Neurosurgery (VUmc) - Medical Specialist
Person: Academic
Mathilde Kouwenhoven
- CCA - Imaging and biomarkers (VUmc) - Medical Specialist
- CCA - Treatment and quality of life (VUmc) - Medical Specialist
- Neurology (VUmc) - Medical Specialist
Person: Academic
Silvia Scoarta
- Neurology (VUmc) - Physician
- Neurosurgery (VUmc) - Standard PhD Candidate
Person: Academic
Arthur Antonius Bergen
- Amsterdam Neuroscience - Complex Trait Genetics (AMC) - Full Professor
- AR&D - Amsterdam Reproduction & Development - Full Professor
- Human Genetics (AMC) - Full Professor
Person: Academic
dr. Wessel van Wieringen
- APH - Methodology (VUmc) - Associate Professor
- Epidemiology and Data Science (VUmc) - Associate Professor
Person: Academic
Pieter Wesseling
- CCA - Cancer biology and immunology (VUmc) - Full Professor
- CCA - Imaging and biomarkers (VUmc) - Full Professor
- AII - Cancer immunology (VUmc) - Full Professor
- Pathology (VUmc) - Full Professor
Person: Academic
Josephine Dorsman
- CCA - Cancer biology and immunology (VUmc) - Research Associate
- Amsterdam Reproduction & Development (VUmc) - Research Associate
- Ophthalmology (VUmc) - Research Associate
Person: Academic
David Bailey
- IOTA Pharmaceuticals Ltd, Cambridge, United Kingdom
- IOTA Pharmaceuticals Ltd
External person
Ariena Kersbergen
- Division of Molecular Pathology, Amsterdam, Netherlands
- Netherlands Cancer Institute
External person
Wendy Sol
- Division of Molecular Pathology, Amsterdam, Netherlands
- Netherlands Cancer Institute
External person
Fredrik Svensson
- IOTA Pharmaceuticals Ltd, Cambridge, United Kingdom
- IOTA Pharmaceuticals Ltd
External person
Deborah A. Elger
- Max Delbrück Center for Molecular Medicine in the Helmholtz Association
External person
Thomas Wijnands
External person
Marina Pajic
- Netherlands Cancer Institute
- Garvan Institute of Medical Research
- University of New South Wales
External person
Marieke van de Ven
- Mouse Clinic for Cancer and Aging Research (MCCA), Amsterdam, Netherlands
External person
Natalie Proost
External person
Hamza Saleem
External person
Thomas J. Jentsch
- Max Delbrück Center for Molecular Medicine in the Helmholtz Association
- Charité – Universitätsmedizin Berlin
External person
Renske de Korte-Grimmerink
- Mouse Clinic for Cancer and Aging Research (MCCA), Amsterdam, Netherlands
External person
Laurine Wedekind
External person
Ravi S. Narayan
External person
Alessia Gasparini
External person
Carolien L. Van der Borden
External person
Dieter H Heiland
External person
U Kulsoom Abdul
External person
Aslı Küçükosmanoglu
External person
S. Momsen Reincke
- Max Delbrück Center for Molecular Medicine in the Helmholtz Association
External person
Tobias Stauber
- Max Delbrück Center for Molecular Medicine in the Helmholtz Association
- Free University of Berlin
External person
Rosa Planells-Cases
- Max Delbrück Center for Molecular Medicine in the Helmholtz Association
External person
Lodewyk Frederik Ary Wessels
- Netherlands Cancer Institute
- Delft University of Technology
External person
Thijn R. Brummelkamp
- Division of Biochemistry, Amsterdam, Netherlands
- Netherlands Cancer Institute
External person
Florian Ullrich
- Max Delbrück Center for Molecular Medicine in the Helmholtz Association
External person
Marleen Dekker
External person
Mark Wolff
External person
Felizia K. Voss
- Max Delbrück Center for Molecular Medicine in the Helmholtz Association
External person